99 related articles for article (PubMed ID: 2110483)
1. Isolated adipocytes from growth hormone-treated obese (ob/ob) mice exhibit insulin resistance.
Roupas P; Towns RJ; Kostyo JL
Biochim Biophys Acta; 1990 May; 1052(2):341-4. PubMed ID: 2110483
[TBL] [Abstract][Full Text] [Related]
2. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
[TBL] [Abstract][Full Text] [Related]
3. The stimulatory effect of insulin on diacylglycerol generation in adipocyte membranes from ob/ob mice is impaired by growth hormone.
Towns R; Kostyo JL; Martin D; Chou SY; Bennink MR
Endocrinology; 1993 Apr; 132(4):1671-6. PubMed ID: 8462467
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
Towns R; Kostyo JL; Colca JR
Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of S-carboxymethylated human growth hormone on insulin resistance in the obese (ob/ob) mouse.
Adamafio NA; Kostyo JL; Cameron CM; Trimark JR; Dunbar JC
Metabolism; 1988 Sep; 37(9):900-5. PubMed ID: 3047525
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes.
Lagathu C; Yvan-Charvet L; Bastard JP; Maachi M; Quignard-Boulangé A; Capeau J; Caron M
Diabetologia; 2006 Sep; 49(9):2162-73. PubMed ID: 16865359
[TBL] [Abstract][Full Text] [Related]
8. Effects of insulin on lipolysis and lipogenesis in adipocytes from genetically obese (ob/ob) mice.
Carnie JA; Smith DG; Mavris-Vavayannis M
Biochem J; 1979 Oct; 184(1):107-12. PubMed ID: 534511
[TBL] [Abstract][Full Text] [Related]
9. Influence of cycloheximide on acute diabetogenic effects of S-carboxymethylated human growth hormone in obese (ob/ob) mice.
Adamafio NA; Cameron CM; Kostyo JL
Horm Metab Res; 1988 Jul; 20(7):391-4. PubMed ID: 3049288
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone inhibits activation of phosphatidylinositol phospholipase C by insulin in ob/ob mouse adipose tissue.
Chou SY; Kostyo JL; Adamafio NA
Endocrinology; 1990 Jan; 126(1):62-6. PubMed ID: 2403523
[TBL] [Abstract][Full Text] [Related]
11. Somatotropin antagonism of insulin-stimulated glucose utilization in 3T3-L1 adipocytes.
Glenn KC; Rose KS; Krivi GG
J Cell Biochem; 1988 Aug; 37(4):371-83. PubMed ID: 3047155
[TBL] [Abstract][Full Text] [Related]
12. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA
Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
[TBL] [Abstract][Full Text] [Related]
13. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
[TBL] [Abstract][Full Text] [Related]
14. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
Chang AY; Wyse BM; Gilchrist BJ
Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
Salem MA; Wolff GL
Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
[TBL] [Abstract][Full Text] [Related]
16. Relationship between increased binding and insulin-like effects of human growth hormone in adipocytes from young fa/fa rats.
Landron D; Guerre-Millo M; Postel-Vinay MC; Lavau M
Endocrinology; 1989 May; 124(5):2305-13. PubMed ID: 2651095
[TBL] [Abstract][Full Text] [Related]
17. Increased insulin binding and glucose transport in white adipocytes isolated from C57B1/6 ob/ob mice treated with the thermogenic beta-adrenoceptor agonist BRL 26830.
Young P; King L; Cawthorne MA
Biochem Biophys Res Commun; 1985 Dec; 133(2):457-61. PubMed ID: 2867764
[TBL] [Abstract][Full Text] [Related]
18. Changes in growth hormone binding and metabolic effects of growth hormone in rat adipocytes following hypophysectomy.
Gause I; Edén S; Isaksson O; DiGirolamo M; Smith U
Acta Physiol Scand; 1985 Jun; 124(2):229-38. PubMed ID: 2990166
[TBL] [Abstract][Full Text] [Related]
19. Antagonism by growth hormone of insulin-sensitive hexose transport in 3T3-F442A adipocytes.
Silverman MS; Mynarcik DC; Corin RE; Haspel HC; Sonenberg M
Endocrinology; 1989 Nov; 125(5):2600-4. PubMed ID: 2676487
[TBL] [Abstract][Full Text] [Related]
20. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
